This Article Full Text Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pimstone, S. N. Articles by Kastelein, J. J.P. Search for Related Content PubMed PubMed Citation Articles by Pimstone, S. N. Articles by Kastelein, J. J.P.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:826-833.)
© 1997 American Heart Association, Inc.

Articles

Differences in the Phenotype Between Children With Familial Defective Apolipoprotein B-100 and Familial Hypercholesterolemia

Simon N. Pimstone; Joep C. Defesche; Susanne M. Clee; Henk D. Bakker; Michael R. Hayden; ; John J.P. Kastelein

From the Department of Medical Genetics, University of British Columbia, Vancouver, Canada (S.N.P., S.M.C., M.R.H.); and the Departments of Vascular Medicine (J.C.D., J.J.P.K.) and Pediatrics (H.D.B.), Academic Medical Centre, University of Amsterdam, The Netherlands.

Correspondence to Dr Michael R. Hayden, Department of Medical Genetics, Room 416-2125 East Mall, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.

Abstract Familial defective apolipoprotein B-100 (FDB) is a dominantly inherited genetic disorder resulting from a point mutation in the apolipoprotein (apo) B gene and is associated with significantly elevated plasma total and LDL cholesterol levels. Despite numerous descriptions outlining the phenotype of children with familial hypercholesterolemia (FH), no study has described the biochemical and clinical phenotype in a cohort of children with FDB. The phenotypes of FH and FDB, therefore, have not been compared in children. We have studied a cohort of 38 Dutch children (all <20 years old) with FDB from 21 different families. Lipid and lipoprotein levels and the clinical phenotype were compared with 97 age-matched FH heterozygotes, as defined by molecular analysis, and with age-matched non-FDB, non-FH control subjects. Female FDB carriers (n=23) had significantly lower total cholesterol (P<.001), LDL cholesterol (P=.001), total cholesterol:HDL ratio (P<.001), and apoB levels (P=.001) than age-matched female FH heterozygotes (n=50). Similar results were noted in male FDB carriers (n=15) compared with male FH heterozygotes (n=47; P=.005, P=.007, P=.014, and P=.074, respectively). Within the FDB group, female FDB heterozygotes had higher LDL cholesterol (P=.038) and a trend to higher total cholesterol levels (P=.165) than age-matched males. Both male and female FDB carriers had significantly higher total cholesterol, LDL cholesterol, and total cholesterol:HDL ratio than age- and sex-matched control subjects, which was evident even in children <10 years of age, providing additional evidence that this mutation is penetrant in early life. These results provide evidence for a milder biochemical phenotype in children with FDB than in children with FH. The phenotype observed is intermediate between that of control subjects and FH heterozygotes matched for age and sex. As the incidence of coronary artery disease is related to both the extent and duration of cholesterol elevation, our findings might explain in part the lower incidence of clinical atherosclerosis seen in adults with this condition than in adults with FH.

Key Words: children • familial hypercholesterolemia • familial defective apoB-100

This article has been cited by other articles:

				M. A. Austin, C. M. Hutter, R. L. Zimmern, and S. E. Humphries Familial Hypercholesterolemia and Coronary Heart Disease: A HuGE Association Review Am. J. Epidemiol., September 1, 2004; 160(5): 421 - 429. [Abstract] [Full Text] [PDF]

				N. Jacobsen, M. Fenger, J. Bentzen, S. L. Rasmussen, M. H. Jakobsen, J. Fenstholt, and J. Skouv Genotyping of the Apolipoprotein B R3500Q Mutation Using Immobilized Locked Nucleic Acid Capture Probes Clin. Chem., April 1, 2002; 48(4): 657 - 660. [Full Text] [PDF]

				J.-P. Rabes, M. Varret, M. Devillers, P. Aegerter, L. Villeger, M. Krempf, C. Junien, and Catherine Boileau R3531C Mutation in the Apolipoprotein B Gene Is Not Sufficient to Cause Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., October 1, 2000; 20 (10): e76 - e82. [Abstract] [Full Text] [PDF]

				D.-Y. Tai, J.-P. Pan, and G.-J. Lee-Chen Identification and haplotype analysis of apolipoprotein B-100 Arg3500->Trp mutation in hyperlipidemic Chinese Clin. Chem., August 1, 1998; 44(8): 1659 - 1665. [Abstract] [Full Text] [PDF]